Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 99.63% is 62% above its 5-year average of 61.51%, near the high end of its 5-year range (0.00%–100.00%).
30.57% above its 12-month average of 76.31%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-06-30): 94.36%.
GROSS MARGIN
99.63%
GROSS MARGIN AVG TTM
76.31%
GROSS MARGIN AVG 3Y
53.52%
GROSS MARGIN AVG 5Y
61.51%
GROSS MARGIN AVG 10Y
53.75%
GROSS MARGIN AVG 15Y
50.63%
GROSS MARGIN AVG 20Y
62.29%
CURRENT VS TTM AVG
+30.57%
CURRENT VS 3Y AVG
+86.17%
CURRENT VS 5Y AVG
+61.97%
CURRENT VS 10Y AVG
+85.35%
CURRENT VS 15Y AVG
+96.79%
CURRENT VS 20Y AVG
+59.96%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+140.77%
vs the sector median at left
Palatin Technologies, Inc.
Market Cap
$17.14M
Gross Margin
99.63%
TTM Avg
76.31%
3Y Avg
53.52%
5Y Avg
61.51%
Market Cap
$17.14M
Gross Margin
-354.93%
TTM Avg
-228.26%
3Y Avg
-369.25%
5Y Avg
-249.00%
Market Cap
$17.07M
Gross Margin
-334.26%
TTM Avg
-117.13%
3Y Avg
-347.18%
5Y Avg
-222.70%
Market Cap
$16.84M
Gross Margin
0.00%
TTM Avg
-52.16%
3Y Avg
-139.89%
5Y Avg
-776.52%
Market Cap
$16.81M
Gross Margin
21.95%
TTM Avg
11.59%
3Y Avg
17.76%
5Y Avg
20.87%
Market Cap
$16.53M
Gross Margin
72.24%
TTM Avg
86.12%
3Y Avg
93.06%
5Y Avg
-220.71%
Market Cap
$16.50M
Gross Margin
-88.25%
TTM Avg
-11.22%
3Y Avg
9.24%
5Y Avg
11.19%
Market Cap
$17.84M
Gross Margin
10.27%
TTM Avg
10.01%
3Y Avg
10.00%
5Y Avg
11.56%
Market Cap
$17.99M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palatin Technologies, Inc. (PTN) | $17.14M | 99.63% | 76.31% | 53.52% | 61.51% |
| PAVmed Inc. (PAVM)vs › | $17.14M | -354.93% | -228.26% | -369.25% | -249.00% |
| Lipocine Inc. (LPCN)vs › | $17.07M | -334.26% | -117.13% | -347.18% | -222.70% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | 0.00% | -52.16% | -139.89% | -776.52% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.81M | 21.95% | 11.59% | 17.76% | 20.87% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.53M | 72.24% | 86.12% | 93.06% | -220.71% |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | -88.25% | -11.22% | 9.24% | 11.19% |
| Cosmos Health Inc. (COSM)vs › | $17.84M | 10.27% | 10.01% | 10.00% | 11.56% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | 0.00% | -3731.89% | -2384.22% | -1567.12% |
Gross Margin
99.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 94.36% |
| 2026-03-31 | 99.57% |
| 2025-12-31 | 87.60% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 51.45% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 86.83% |
| 2023-09-30 | 91.65% |
| 2023-06-30 | 84.26% |
| 2023-03-31 | 74.79% |
| 2022-12-31 | 90.38% |
| 2022-09-30 | 90.05% |
| 2022-06-30 | 88.65% |
| 2022-03-31 | 16.57% |
| 2021-12-31 | 90.94% |
| 2021-09-30 | 66.18% |
| 2021-06-30 | 78.42% |
| 2021-03-31 | 37.53% |
| 2020-12-31 | 117.93% |
| 2020-09-30 | 108.73% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | 100.00% |
| 2019-06-30 | 92.82% |
| 2019-03-31 | -11330.18% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | -10399.03% |
| 2018-06-30 | 74.35% |
| 2018-03-31 | 21.13% |
| 2017-12-31 | 43.03% |
| 2017-09-30 | 47.43% |
| 2017-06-30 | 49.09% |
| 2017-03-31 | 16.27% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | -3.72% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 154.65% |
| 2015-03-31 | -53.85% |
| 2014-12-31 | 46.71% |
| 2014-09-30 | 40.72% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 54689.33% |
| 2013-03-31 | -77266.97% |
| 2012-12-31 | -37211.52% |
| 2012-09-30 | -61468.92% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 100.00% |
| 2010-12-31 | 100.00% |
| 2010-09-30 | 100.00% |
| 2010-06-30 | 100.00% |
| 2010-03-31 | 100.00% |
| 2009-12-31 | 100.00% |
| 2009-09-30 | 100.00% |
| 2009-06-30 | 100.00% |
| 2009-03-31 | 100.00% |
| 2008-12-31 | 100.00% |
| 2008-09-30 | 100.00% |
| 2008-06-30 | 100.00% |
| 2008-03-31 | 100.00% |
| 2007-12-31 | 100.00% |
| 2007-09-30 | 100.00% |
| 2007-06-30 | -325.58% |
| 2007-03-31 | 100.00% |
| 2006-12-31 | -199.87% |
| 2006-09-30 | 100.00% |
| 2006-06-30 | -40906.54% |
| 2006-03-31 | 100.00% |
| 2005-12-31 | 55.50% |
| 2005-09-30 | 100.00% |
| 2005-06-30 | 93.30% |
| 2005-03-31 | 96.75% |
| 2004-12-31 | 95.42% |
| 2004-09-30 | 98.04% |
| 2004-06-30 | 100.00% |
| 2004-03-31 | 100.00% |
| 2003-12-31 | 100.00% |
| 2003-09-30 | 100.00% |
| 2003-06-30 | 100.00% |
| 2003-03-31 | 100.00% |
| 2002-12-31 | 100.00% |
| 2002-09-30 | 100.00% |
